Clinical Trials Directory

Trials / Completed

CompletedNCT00666003

Hemodynamic Assessment APCO Monitor vs Crit Line for Renal Replacement Rx

Hemodynamic Assessment Comparison Between Arterial Pressure Cardiac Output Monitor and Crit Line Utilized During Renal Replacement Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
Baystate Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Fluid and volume management are a challenging part of critical care and the difficulties increase in the face of renal failure. Utilizing the Crit-Line to monitor blood volume changes in conjunction with arterial pressure cardiac output monitoring may lead to better understanding of the impact fluid removal during dialysis has on hemodynamics.

Detailed description

Patients in an ICU often require large amounts of IV fluid to maintain adequate cardiac function. In patients with renal failure, the ability to gauge adequacy of circulating blood volume based on urine output is obviously lacking. The FDA approved devices called Flotrac/Vigileo and Crit-Line are used in this setting to determine adequacy of fluid resuscitation. This study proposes to use the data collected in a retrospective manner to determine if correlation of the various measured parameters can serve as a predictor of hemodynamic status.

Conditions

Timeline

Start date
2008-04-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2008-04-24
Last updated
2011-02-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00666003. Inclusion in this directory is not an endorsement.

Hemodynamic Assessment APCO Monitor vs Crit Line for Renal Replacement Rx (NCT00666003) · Clinical Trials Directory